Industry Research Reports

Home > Reports > Medical Care > RSV Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

RSV Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 87 Pages

Report ld: 2332306

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Respiratory Syncytial Virus (RSV) diagnostics refer to the various methods and tests used to detect and diagnose RSV infections. These diagnostics play a crucial role in identifying and managing RSV infections, especially in infants and young children who are more susceptible to severe respiratory illness caused by the virus.

The global market for RSV Diagnostics was estimated to be worth US$ 743.5 million in 2023 and is forecast to a readjusted size of US$ 1331 million by 2030 with a CAGR of 8.7% during the forecast period 2024-2030

RSV Diagnostics Market Size

M= millions and B=billions

The RSV diagnostics market has been experiencing significant growth due to the high prevalence of RSV infections, especially among infants and young children. The market is driven by factors such as increasing awareness about RSV infections, advancements in diagnostic technologies, and the growing need for accurate and rapid diagnosis. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for RSV Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RSV Diagnostics by region & country, by Type, and by Application.

The RSV Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RSV Diagnostics.

Market Segmentation

Report Metric
Details
Report Title
RSV Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1331 million
CAGR(2024-2030)
8.7%
Market Size Available for Years
2019-2030
Global RSV Diagnostics Companies Covered
BioMérieux, Abbott, Roche, BD, Thermo Fisher, Luminex, Danaher, Biocartis, Hologic
Global RSV Diagnostics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global RSV Diagnostics Market, Segment by Type
Kits and Assays

Instruments

Other
Global RSV Diagnostics Market, Segment by Application
Hospitals & Clinics

Clinical Laboratories

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of RSV Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of RSV Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of RSV Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 RSV Diagnostics Product Introduction
    1.2 Global RSV Diagnostics Market Size Forecast
    1.3 RSV Diagnostics Market Trends & Drivers
        1.3.1 RSV Diagnostics Industry Trends
        1.3.2 RSV Diagnostics Market Drivers & Opportunity
        1.3.3 RSV Diagnostics Market Challenges
        1.3.4 RSV Diagnostics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global RSV Diagnostics Players Revenue Ranking (2023)
    2.2 Global RSV Diagnostics Revenue by Company (2019-2024)
    2.3 Key Companies RSV Diagnostics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies RSV Diagnostics Product Offered
    2.5 Key Companies Time to Begin Mass Production of RSV Diagnostics
    2.6 RSV Diagnostics Market Competitive Analysis
        2.6.1 RSV Diagnostics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by RSV Diagnostics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV Diagnostics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Kits and Assays
        3.1.2 Instruments
        3.1.3 Other
    3.2 Global RSV Diagnostics Sales Value by Type
        3.2.1 Global RSV Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global RSV Diagnostics Sales Value, by Type (2019-2030)
        3.2.3 Global RSV Diagnostics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals & Clinics
        4.1.2 Clinical Laboratories
        4.1.3 Other
    4.2 Global RSV Diagnostics Sales Value by Application
        4.2.1 Global RSV Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global RSV Diagnostics Sales Value, by Application (2019-2030)
        4.2.3 Global RSV Diagnostics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global RSV Diagnostics Sales Value by Region
        5.1.1 Global RSV Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global RSV Diagnostics Sales Value by Region (2019-2024)
        5.1.3 Global RSV Diagnostics Sales Value by Region (2025-2030)
        5.1.4 Global RSV Diagnostics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America RSV Diagnostics Sales Value, 2019-2030
        5.2.2 North America RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe RSV Diagnostics Sales Value, 2019-2030
        5.3.2 Europe RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific RSV Diagnostics Sales Value, 2019-2030
        5.4.2 Asia Pacific RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America RSV Diagnostics Sales Value, 2019-2030
        5.5.2 South America RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa RSV Diagnostics Sales Value, 2019-2030
        5.6.2 Middle East & Africa RSV Diagnostics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions RSV Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions RSV Diagnostics Sales Value
    6.3 United States
        6.3.1 United States RSV Diagnostics Sales Value, 2019-2030
        6.3.2 United States RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States RSV Diagnostics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe RSV Diagnostics Sales Value, 2019-2030
        6.4.2 Europe RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe RSV Diagnostics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China RSV Diagnostics Sales Value, 2019-2030
        6.5.2 China RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China RSV Diagnostics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan RSV Diagnostics Sales Value, 2019-2030
        6.6.2 Japan RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan RSV Diagnostics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea RSV Diagnostics Sales Value, 2019-2030
        6.7.2 South Korea RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea RSV Diagnostics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia RSV Diagnostics Sales Value, 2019-2030
        6.8.2 Southeast Asia RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia RSV Diagnostics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India RSV Diagnostics Sales Value, 2019-2030
        6.9.2 India RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India RSV Diagnostics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 BioMérieux
        7.1.1 BioMérieux Profile
        7.1.2 BioMérieux Main Business
        7.1.3 BioMérieux RSV Diagnostics Products, Services and Solutions
        7.1.4 BioMérieux RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.1.5 BioMérieux Recent Developments
    7.2 Abbott
        7.2.1 Abbott Profile
        7.2.2 Abbott Main Business
        7.2.3 Abbott RSV Diagnostics Products, Services and Solutions
        7.2.4 Abbott RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.2.5 Abbott Recent Developments
    7.3 Roche
        7.3.1 Roche Profile
        7.3.2 Roche Main Business
        7.3.3 Roche RSV Diagnostics Products, Services and Solutions
        7.3.4 Roche RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.3.5 BD Recent Developments
    7.4 BD
        7.4.1 BD Profile
        7.4.2 BD Main Business
        7.4.3 BD RSV Diagnostics Products, Services and Solutions
        7.4.4 BD RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.4.5 BD Recent Developments
    7.5 Thermo Fisher
        7.5.1 Thermo Fisher Profile
        7.5.2 Thermo Fisher Main Business
        7.5.3 Thermo Fisher RSV Diagnostics Products, Services and Solutions
        7.5.4 Thermo Fisher RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.5.5 Thermo Fisher Recent Developments
    7.6 Luminex
        7.6.1 Luminex Profile
        7.6.2 Luminex Main Business
        7.6.3 Luminex RSV Diagnostics Products, Services and Solutions
        7.6.4 Luminex RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.6.5 Luminex Recent Developments
    7.7 Danaher
        7.7.1 Danaher Profile
        7.7.2 Danaher Main Business
        7.7.3 Danaher RSV Diagnostics Products, Services and Solutions
        7.7.4 Danaher RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.7.5 Danaher Recent Developments
    7.8 Biocartis
        7.8.1 Biocartis Profile
        7.8.2 Biocartis Main Business
        7.8.3 Biocartis RSV Diagnostics Products, Services and Solutions
        7.8.4 Biocartis RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.8.5 Biocartis Recent Developments
    7.9 Hologic
        7.9.1 Hologic Profile
        7.9.2 Hologic Main Business
        7.9.3 Hologic RSV Diagnostics Products, Services and Solutions
        7.9.4 Hologic RSV Diagnostics Revenue (US$ Million) & (2019-2024)
        7.9.5 Hologic Recent Developments

 8 Industry Chain Analysis
    8.1 RSV Diagnostics Industrial Chain
    8.2 RSV Diagnostics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 RSV Diagnostics Sales Model
        8.5.2 Sales Channel
        8.5.3 RSV Diagnostics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. RSV Diagnostics Market Trends
    Table 2. RSV Diagnostics Market Drivers & Opportunity
    Table 3. RSV Diagnostics Market Challenges
    Table 4. RSV Diagnostics Market Restraints
    Table 5. Global RSV Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global RSV Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies RSV Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies RSV Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of RSV Diagnostics
    Table 10. Global RSV Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RSV Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global RSV Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global RSV Diagnostics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global RSV Diagnostics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global RSV Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global RSV Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global RSV Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global RSV Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global RSV Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global RSV Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global RSV Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global RSV Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global RSV Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global RSV Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global RSV Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global RSV Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions RSV Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions RSV Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions RSV Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. BioMérieux Basic Information List
    Table 32. BioMérieux Description and Business Overview
    Table 33. BioMérieux RSV Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in RSV Diagnostics Business of BioMérieux (2019-2024)
    Table 35. BioMérieux Recent Developments
    Table 36. Abbott Basic Information List
    Table 37. Abbott Description and Business Overview
    Table 38. Abbott RSV Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in RSV Diagnostics Business of Abbott (2019-2024)
    Table 40. Abbott Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche RSV Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in RSV Diagnostics Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. BD Basic Information List
    Table 47. BD Description and Business Overview
    Table 48. BD RSV Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in RSV Diagnostics Business of BD (2019-2024)
    Table 50. BD Recent Developments
    Table 51. Thermo Fisher Basic Information List
    Table 52. Thermo Fisher Description and Business Overview
    Table 53. Thermo Fisher RSV Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in RSV Diagnostics Business of Thermo Fisher (2019-2024)
    Table 55. Thermo Fisher Recent Developments
    Table 56. Luminex Basic Information List
    Table 57. Luminex Description and Business Overview
    Table 58. Luminex RSV Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in RSV Diagnostics Business of Luminex (2019-2024)
    Table 60. Luminex Recent Developments
    Table 61. Danaher Basic Information List
    Table 62. Danaher Description and Business Overview
    Table 63. Danaher RSV Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in RSV Diagnostics Business of Danaher (2019-2024)
    Table 65. Danaher Recent Developments
    Table 66. Biocartis Basic Information List
    Table 67. Biocartis Description and Business Overview
    Table 68. Biocartis RSV Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in RSV Diagnostics Business of Biocartis (2019-2024)
    Table 70. Biocartis Recent Developments
    Table 71. Hologic Basic Information List
    Table 72. Hologic Description and Business Overview
    Table 73. Hologic RSV Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in RSV Diagnostics Business of Hologic (2019-2024)
    Table 75. Hologic Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. RSV Diagnostics Downstream Customers
    Table 79. RSV Diagnostics Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. RSV Diagnostics Product Picture
    Figure 2. Global RSV Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global RSV Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. RSV Diagnostics Report Years Considered
    Figure 5. Global RSV Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by RSV Diagnostics Revenue in 2023
    Figure 7. RSV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Kits and Assays Picture
    Figure 9. Instruments Picture
    Figure 10. Other Picture
    Figure 11. Global RSV Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global RSV Diagnostics Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals & Clinics
    Figure 14. Product Picture of Clinical Laboratories
    Figure 15. Product Picture of Other
    Figure 16. Global RSV Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global RSV Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America RSV Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe RSV Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific RSV Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America RSV Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa RSV Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa RSV Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions RSV Diagnostics Sales Value (%), (2019-2030)
    Figure 29. United States RSV Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States RSV Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe RSV Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe RSV Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China RSV Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 37. China RSV Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan RSV Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan RSV Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea RSV Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea RSV Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia RSV Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia RSV Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India RSV Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India RSV Diagnostics Sales Value by Type (%), 2023 VS 2030
    Figure 49. India RSV Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. RSV Diagnostics Industrial Chain
    Figure 51. RSV Diagnostics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

Respiratory Syncytial Virus (RSV) diagnostics refer to the various methods and tests used to detect and diagnose RSV infections. These diagnostics play a crucial role in identifying and managing RSV infections, especially in infants and young children who are more susceptible to severe respiratory illness caused by the virus.

The global market for RSV Diagnostics was estimated to be worth US$ 743.5 million in 2023 and is forecast to a readjusted size of US$ 1331 million by 2030 with a CAGR of 8.7% during the forecast period 2024-2030

The RSV diagnostics market has been experiencing significant growth due to the high prevalence of RSV infections, especially among infants and young children. The market is driven by factors such as increasing awareness about RSV infections, advancements in diagnostic technologies, and the growing need for accurate and rapid diagnosis. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for RSV Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of RSV Diagnostics by region & country, by Type, and by Application.

The RSV Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RSV Diagnostics.

Market Segmentation